126 related articles for article (PubMed ID: 30377215)
1. A Comparison of the Central versus Peripheral Gastrointestinal Prokinetic Activity of Two Novel Ghrelin Mimetics.
Mohammadi EN; Pietra C; Giuliano C; Fugang L; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2019 Jan; 368(1):116-124. PubMed ID: 30377215
[TBL] [Abstract][Full Text] [Related]
2. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists.
Charoenthongtrakul S; Giuliana D; Longo KA; Govek EK; Nolan A; Gagne S; Morgan K; Hixon J; Flynn N; Murphy BJ; Hernández AS; Li J; Tino JA; Gordon DA; DiStefano PS; Geddes BJ
J Pharmacol Exp Ther; 2009 Jun; 329(3):1178-86. PubMed ID: 19252061
[TBL] [Abstract][Full Text] [Related]
3. New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
Karasawa H; Pietra C; Giuliano C; Garcia-Rubio S; Xu X; Yakabi S; Taché Y; Wang L
Neurogastroenterol Motil; 2014 Dec; 26(12):1771-82. PubMed ID: 25327342
[TBL] [Abstract][Full Text] [Related]
4. Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus.
Venkova K; Fraser G; Hoveyda HR; Greenwood-Van Meerveld B
Dig Dis Sci; 2007 Sep; 52(9):2241-8. PubMed ID: 17436082
[TBL] [Abstract][Full Text] [Related]
5. Site and mechanism of the colokinetic action of the ghrelin receptor agonist, HM01.
Naitou K; Mamerto TP; Pustovit RV; Callaghan B; Rivera LR; Chan AJ; Ringuet MT; Pietra C; Furness JB
Neurogastroenterol Motil; 2015 Dec; 27(12):1764-71. PubMed ID: 26416336
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus.
Venkova K; Mann W; Nelson R; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2009 Jun; 329(3):1110-6. PubMed ID: 19289567
[TBL] [Abstract][Full Text] [Related]
7. The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew).
Tu L; Lu Z; Ngan MP; Lam FFY; Giuliano C; Lovati E; Pietra C; Rudd JA
Br J Pharmacol; 2020 Apr; 177(7):1635-1650. PubMed ID: 31722444
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models.
Chiorazzi A; Wozniak KM; Rais R; Wu Y; Gadiano AJ; Farah MH; Liu Y; Canta A; Alberti P; Rodriguez-Menendez V; Meregalli C; Fumagalli G; Monza L; Pozzi E; Vornov JJ; Polydefkis M; Pietra C; Slusher BS; Cavaletti G
Eur J Pharmacol; 2018 Dec; 840():89-103. PubMed ID: 30268665
[TBL] [Abstract][Full Text] [Related]
9. Effect of the ghrelin receptor agonist TZP-101 on colonic transit in a rat model of postoperative ileus.
Fraser GL; Venkova K; Hoveyda HR; Thomas H; Greenwood-Van Meerveld B
Eur J Pharmacol; 2009 Feb; 604(1-3):132-7. PubMed ID: 19121631
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin as a target for gastrointestinal motility disorders.
Greenwood-Van Meerveld B; Kriegsman M; Nelson R
Peptides; 2011 Nov; 32(11):2352-6. PubMed ID: 21453735
[TBL] [Abstract][Full Text] [Related]
11. Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats.
Tebbe JJ; Tebbe CG; Mronga S; Ritter M; Schäfer MK
BMC Gastroenterol; 2005 Feb; 5():5. PubMed ID: 15720710
[TBL] [Abstract][Full Text] [Related]
12. Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT
Rudd JA; Chan SW; Ngan MP; Tu L; Lu Z; Giuliano C; Lovati E; Pietra C
Front Pharmacol; 2018; 9():869. PubMed ID: 30127745
[TBL] [Abstract][Full Text] [Related]
13. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
[TBL] [Abstract][Full Text] [Related]
14. Naringin exhibits in vivo prokinetic activity via activation of ghrelin receptor in gastrointestinal motility dysfunction rats.
Jang Y; Kim TK; Shim WS
Pharmacology; 2013; 92(3-4):191-7. PubMed ID: 24080610
[TBL] [Abstract][Full Text] [Related]
15. [Effect of ghrelin on small intestinal transit and interdigestive gastrointestinal migrating myoelectric complex in rats].
Wang Y; Dong L; Zhao P; Cheng Y; Li HP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):328-32. PubMed ID: 18359683
[TBL] [Abstract][Full Text] [Related]
16. Effect of spinal cord stimulation in a rodent model of post-operative ileus.
Maher J; Johnson AC; Newman R; Mendez S; Hoffmann TJ; Foreman R; Greenwood-Van Meerveld B
Neurogastroenterol Motil; 2009 Jun; 21(6):672-7, e33-4. PubMed ID: 19175749
[TBL] [Abstract][Full Text] [Related]
17. Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131.
Van der Ploeg L; Laken H; Sharma S; Datta R; Halem H; Dong J; Touvay C; Teillot M; Noonan P; Tartaglia L; Stoner L; Henderson B; Gottesdiener K; Culler M
Life Sci; 2014 Jul; 109(1):20-9. PubMed ID: 24931905
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin improves burn-induced delayed gastrointestinal transit in rats.
Sallam HS; Oliveira HM; Gan HT; Herndon DN; Chen JD
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R253-7. PubMed ID: 16959863
[TBL] [Abstract][Full Text] [Related]
19. The ghrelin agonist, HM01 activates central vagal and enteric cholinergic neurons and reverses gastric inflammatory and ileus responses in rats.
Yuan PQ; Wu SV; Wang L; Taché Y
Neurogastroenterol Motil; 2023 May; 35(5):e14561. PubMed ID: 36942655
[TBL] [Abstract][Full Text] [Related]
20. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats.
Minalyan A; Gabrielyan L; Pietra C; Taché Y; Wang L
Front Integr Neurosci; 2019; 13():13. PubMed ID: 31031602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
